The Omnipod 5 Automated Insulin Delivery System is now commercially available in Italy, Denmark, Finland, Norway, and Sweden with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6
ACTON, Mass., January 13, 2025–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now commercially available in five more countries—Italy, Denmark, Finland, Norway, and Sweden.
Omnipod 5 is now available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensor compatibility. Indicated for individuals aged two years and older with type 1 diabetes, Omnipod 5 is the first and only tubeless automated insulin delivery (AID) system integrated with both leading CGM sensor brands.
“We are excited to bring our flagship Omnipod 5 AID System to more people across Europe,” said Patrick Crannell, Insulet Senior Vice President and International General Manager. “Following our successful launches of Omnipod 5 in the U.K., Germany, Netherlands, and France, today’s announcement marks another significant step forward to help improve the lives of people with diabetes around the world.”
Omnipod is recognized as the number one insulin pump for new pump users in Europe1. Omnipod 5 is also the number one prescribed AID system in the U.S.2 and the first tubeless, waterproof3 AID system with proactive glucose control designed to deliver exceptional ease of use. It was first introduced in the U.S. in 2022, integrated with Dexcom G6, and has demonstrated strong clinical results with real world evidence including lower A1c and improved time in range, while maintaining low time in hypoglycemia.4,5,6
“I can’t wait to get my Omnipod 5 so I can think less about diabetes,” said Lina, a 45-year-old resident of Sweden who has lived with type 1 diabetes for over 20 years. “I had to inject insulin multiple times per day for many years, but I have also been using a tubed insulin pump. Now that Omnipod 5 is available, I am excited to see what difference a tubeless and waterproof AID system will make when doing sports, wearing nice dresses, and skiing. My worry and stress that comes with managing this chronic condition will hopefully lessen, and my active life with diabetes may become simpler.”
Sensor integration with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 allows many users to benefit from Omnipod 5 with their sensor of choice. It also gives prescribers more flexibility when recommending a sensor for their patients, making it fast and easy to start AID therapy with Omnipod 5.
Story Continues